Skip to main content
Data in Brief logoLink to Data in Brief
. 2016 Feb 27;7:873–876. doi: 10.1016/j.dib.2016.02.050

Data on single-step purification method for dye-labeled DNA sequencing

Kohei Fujikura 1,1
PMCID: PMC4816862  PMID: 27077088

Abstract

Dye-labelled DNA sequencing is one of the most common and robust technique required for molecular biology since 1977 (Sanger, 1977) [1]. I have recently provided the single-step purification method for dye-labeled sequencing products, which is based on the removal of the washing step in EDTA/ethanol precipitation (Fujikura, 2015) [2]. Here I assess and report the accumulated data of the modified method on the larger scale in practice.

Keywords: DNA sequencing, Purification, Ethanol precipitation, EDTA, Quality value


Specifications Table

Subject area Molecular biology
More specific subject area DNA sequencing
Type of data Graph
How data was acquired DNA sequencer
Data format Analyzed data
Experimental factors Dye-labeled sequencing reaction is performed in specified dilution rate.
Experimental features The modified EDTA/ethanol method skips the washing step in EDTA/ethanol precipitation for dye-labeled DNA sequencing.
Data source location Japan
Data accessibility The data are with this article.

Value of the data

  • The data provide the scheme and characterize the success rate for modified EDTA/ethanol purification method for dye-labeled DNA sequencing.

  • The data provide the optimization of methods, including the amount of DNA template, primers, and buffer conditions for rapid purification of dye-labeled sequencing.

  • The modified method provides the quick and inexpensive purification technique for DNA sequencing.

1. Data

Dye-labeled DNA sequencing technique is still an important tool for clinical decision making on cancer [3], [4], [5], drug metabolism genotyping [6], [7], [8], pathogen identification [9], [10], [11], inherited disease [12], [13], [14], [15], [16], [17] and so on [18], [19]. However, the methods remain laborious and time-consuming. Here I modified sequencing method and assessed its data quality (Fig. 1). The modified method requires only 10 min, whereas commercial purification kits and standard ethanol precipitation require a longer processing time. DNA sequences of more than 850–900 bp were more stably obtained in a single sequencing reaction with this rapid method without compromising high-quality base calling and read length (916±35 bp, n=168, QV>20). (Fig. 1). The read length obtained by this method was significantly longer than that obtained by standard methods (modified EDTA vs. standard EDTA (877±37 bp, n=168); P<0.01) (Fig. 1). The failure rate of modified method was quite low (0.6%; 1/168).

Fig. 1.

Fig. 1

(A) Method for the single-step purification of dye-labeled sequencing products is described in left half. (B) Comparison of the sequence read lengths with QV>20 in two different methods is shown in right graph. Results are shown as the means±standard deviations (Student t tests; P<0.01).

2. Experimental design, materials and methods

2.1. Sequencing reaction

Sequencing reaction was performed in a 10 μl scale using the BigDye Terminator v3.1 Cycle Sequencing Kit (dilution rate: 1:16–1:32) (Applied Biosystems, Foster City, CA, USA), 10 pmol of various primers, and 50–1500 ng of template DNA (50 ng for 100–300 bp PCR product, 250 ng for 300–2000 bp PCR product, or 1500 ng for plasmid) for one experimental run. The following thermal cycle was used for the amplifications: 96 °C for 1 min, followed by 40–50 cycles of 96 °C for 10 s, 50–58 °C for 5 s and 60 °C for 150 s.

2.2. Modified purification technique and data analysis

1 μl of 125 mM of EDTA and 30 μl of 100% ethanol were added to each sequencing reaction, and the mixture was then lightly vortexed (Fig. 1). After centrifugation (15,000g, 5 min for tube; 4000 g, 15 min for plate), the supernatant was carefully aspirated and discarded. Next, after drying the precipitate, 40 μl of distilled water or TE0.1 buffer (10 mM Tris–acetate [pH 8.0] + 0.1 mM EDTA) was added to each reaction. ABI PRISM 3130 Genetic analyzer and POP-7 polymer were used as the separation machine and matrices, but the other Genetic analyzer (ABI Prism 310, 3730, or 3500) and polymers (POP-4 or POP-6) are also applicable. The sequence data was analyzed with ABI Prism DNA Sequencing Analysis Software v5.1. The quality value score 20 (QV20) was used as indicator of sequencing quality. Student׳s t tests were performed to evaluate the significance between two methods.

Acknowledgments

The author thanks the National Center for Biotechnology Information (NCBI) for the reference sequences and blast searches.

Footnotes

Appendix A

Supplementary data associated with this article can be found in the online version at doi:10.1016/j.dib.2016.02.050.

Appendix A. Supplementary material

Supplementary material

mmc1.pdf (1.2MB, pdf)

References

  • 1.Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA. 1977;74:5463–5467. doi: 10.1073/pnas.74.12.5463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Fujikura K. No-wash ethanol precipitation of dye-labeled reaction products improves DNA sequencing reads. Anal. Biochem. 2015;468:39–41. doi: 10.1016/j.ab.2014.09.010. [DOI] [PubMed] [Google Scholar]
  • 3.Hartman D.J., Binion D., Regueiro M., Schraut W., Bahary N., Sun W., Nikiforova M., Pai R.K. Isocitrate dehydrogenase-1 is mutated in inflammatory bowel disease–associated intestinal adenocarcinoma with low-grade tubuloglandular histology but not in sporadic intestinal adenocarcinoma. Am. J. Surg. Pathol. 2014;38:1147–1156. doi: 10.1097/PAS.0000000000000239. [DOI] [PubMed] [Google Scholar]
  • 4.Lee S., Barnhill R.L., Dummer R., Dalton J., Wu J., Pappo A., Bahrami. A. TERT promoter mutations are predictive of aggressive clinical behavior in patients with spitzoid melanocytic neoplasms. Sci. Rep. 2015;5:11200. doi: 10.1038/srep11200. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kleinschmidt-DeMasters B.K., Aisner D.L., Foreman. N.K. BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation. Am. J. Surg. Pathol. 2015;39:528–540. doi: 10.1097/PAS.0000000000000363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Roberts R.L., Wallace M.C., Drake J.M., Stamp L.K. Identification of a novel thiopurine S-methyltransferase allele (TPMT*37) Pharmacogenet. Genom. 2014;24:320–323. doi: 10.1097/FPC.0000000000000049. [DOI] [PubMed] [Google Scholar]
  • 7.Fohner A.E., Robinson R., Yracheta J., Dillard D.A., Schilling B., Khan B., Hopkins S., Boyer B.B., Black J., Wiener H., Tiwari H.K., Gordon A., Nickerson D., Tsai J.M., Farin F.M., Thornton T.A., Rettie A.E., Thummel K.E. Variation in genes controlling warfarin disposition and response in American Indian and Alaska Native people: CYP2C9, VKORC1, CYP4F2, CYP4F11, GGCX. Pharmacogenet. Genom. 2015;25:343–353. doi: 10.1097/FPC.0000000000000143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Dahlin A., Wittwer M., de la Cruz M., Woo J.M., Bam R., Scharen-Guivel V., Flaherty J., Ray A.S., Cihlar T., Gupta S.K., Giacomini. K.M. A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome. Pharmacogenet. Genom. 2015;25:82–92. doi: 10.1097/FPC.0000000000000110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chen L., Cai Y., Zhou G., Shi X., Su J., Chen G., Lin. K. Rapid Sanger sequencing of the 16S rRNA gene for identification of some common pathogens. PLoS One. 2014;9:e88886. doi: 10.1371/journal.pone.0088886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fukuda K., Yatera K., Ogawa M., Kawanami T., Yamasaki K., Noguchi S., Murphy R.S., Mukae H., Taniguchi. H. An unclassified microorganism: novel pathogen candidate lurking in human airways. PLoS ONE. 2014;9:e103646. doi: 10.1371/journal.pone.0103646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Deng Y.M., Spirason N., Iannello P., Jelley L., Lau H., Barr. I.G. A simplified Sanger sequencing method for full genome sequencing of multiple subtypes of human influenza A viruses. J. Clin. Virol. 2015;68:43–48. doi: 10.1016/j.jcv.2015.04.019. [DOI] [PubMed] [Google Scholar]
  • 12.Kheradmand Kia S., Verbeek E., Engelen E., Schot R., Poot R.A., de Coo I.F., Lequin M.H., Poulton C.J., Pourfarzad F., Grosveld F.G., Brehm A., de Wit M.C., Oegema R., Dobyns W.B., Verheijen F.W., Mancini G.M. RTTN mutations link primary cilia function to organization of the human cerebral cortex. Am. J. Hum. Genet. 2012;91:533–540. doi: 10.1016/j.ajhg.2012.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Osoegawa K., Schultz K., Yun K., Mohammed N., Shaw G.M., Lammer E.J. Haploinsuffciency of insulin gene enhancer protein 1 (ISL1) is associated with d-transposition of the great arteries. Mol. Genet. Genom. Med. 2014;2:341–351. doi: 10.1002/mgg3.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Handley M.T., Mégarbané A., Meynert A.M., Brown S., Freyer E., Taylor M.S., Jackson I.J., Aligianis I.A. Loss of ALDH18A1 function is associated with a cellular lipid droplet phenotype suggesting a link between autosomal recessive cutis laxa type 3A and Warburg Micro syndrome. Mol. Genet. Genomic Med. 2014;2:319–325. doi: 10.1002/mgg3.70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Pérez-Coria M., Lugo-Trampe J.J., Zamudio-Osuna M., Rodríguez-Sánchez I.P., Lugo-Trampe A., de la Fuente-Cortez B., Campos-Acevedo L.D., Martínez-de-Villarreal L.E. Identification of novel mutations in Mexican patients with Aarskog-Scott syndrome. Mol. Genet. Genom. Med. 2015;2:197–202. doi: 10.1002/mgg3.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Baikara B.T., Zholdybayeva E.V., Rakhimova S.E., Nigmatullina N.B., Momynaliev K.T., Ramanculov. Y.M., Novel A. Mutation in a kazakh family with X-linked alport syndrome. PLoS One. 2015;10:e0132010. doi: 10.1371/journal.pone.0132010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hirotsu Y., Nakagomi H., Sakamoto I., Amemiya K., Oyama T., Mochizuki H., Omata M. Multigene panel analysis identified germline mutations of DNA repair genes in breast and ovarian cancer. Mol. Genet. Genom. Med. 2015;3:459–466. doi: 10.1002/mgg3.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Soma M., Fujihara Y., Okabe M., Ishino F., Kobayashi S. Ftx is dispensable for imprinted X-chromosome inactivation in preimplantation mouse embryos. Sci. Rep. 2014;4:5181. doi: 10.1038/srep05181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Janezic S., Indra A., Rattei T., Weinmaier T., Rupnik M. Recombination drives evolution of the Clostridium difficile 16S-23S rRNA intergenic spacer region. PLoS One. 2014;9:e106545. doi: 10.1371/journal.pone.0106545. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary material

mmc1.pdf (1.2MB, pdf)

Articles from Data in Brief are provided here courtesy of Elsevier

RESOURCES